09:12 AM EDT, 07/15/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Monday that it has launched L-Glutamine Oral Powder after the US Food and Drug Administration approved it.

The company said US annual sales for L-Glutamine Oral Powder, which is the generic equivalent of Endari, are about $20.1 million, based on IQVIA data from May 2024.

ANI shares were 3% higher in premarket trading.

Price: 65.41, Change: +1.91, Percent Change: +3.01